What does LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING do?

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is a healthcare practice in Gent. Non-profit, started on 9 March 1999.

What is the address of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING?

The registered office of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is located at Steenvoordelaan 56, 9050 Gent.

Is LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING still active?

Not as usual. The CBE lists LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING with legal situation “Vrijwillige ontbinding – vereffening”.

Is LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING registered on Peppol?

Yes, LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is registered on the Peppol network with ID 0208:0466941667.

Who are the directors of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING?

According to the 2025 annual accounts, the directors of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING are: Céline VandeVyver.

Is LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 9 March 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING make in 2025?

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING recorded a loss after taxes of € 3,589 in financial year 2025.

What is the revenue of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING?

As a small company, LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 173,478.

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING (Non-profit)

Q: What is the enterprise number of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING?

The enterprise number of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is BE0466941667.

Q: When was LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING founded?

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING was founded on 9 March 1999.

Dossier LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING, printed on 1 November 2026 from databakkes.be/en/0466941667/life-care-dringende-geneeskundige-hulpverlening. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING from Gent, company number BE0466941667, closed financial year 2025 with a result of € -3,589 after tax. For that financial year LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING recorded a gross margin of € 173,478 and equity of € 25,778. Compared with financial year 2024, the result moved from € -5,916 to € -3,589. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Healthy

€ 25,778

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -3,589

▲ 39 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 66,358

▼ 36% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 176,069

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

€ 323

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 71,657

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 234,490 Gross margin 2022: € 234,490 First fiscal year in the series	€ 216,553 Gross margin 2023: € 216,553 ▼ 8% vs 2022 (€ 234,490) Unfavourable step	€ 170,511 Gross margin 2024: € 170,511 ▼ 21% vs 2023 (€ 216,553) Unfavourable step	€ 173,478 Gross margin 2025: € 173,478 ▲ 2% vs 2024 (€ 170,511) Favourable step	▲ 2%
Profit after taxes	€ 9,626 Profit after taxes 2022: € 9,626 First fiscal year in the series	€ 4,606 Profit after taxes 2023: € 4,606 ▼ 52% vs 2022 (€ 9,626) Unfavourable step	€ -5,916 Profit after taxes 2024: € -5,916 ▼ € 10,522 vs 2023 (€ 4,606) Unfavourable step	€ -3,589 Profit after taxes 2025: € -3,589 ▲ € 2,327 vs 2024 (€ -5,916) Favourable step	▲ € 2,327
Equity	€ 30,678 Equity 2022: € 30,678 First fiscal year in the series	€ 35,283 Equity 2023: € 35,283 ▲ 15% vs 2022 (€ 30,678) Favourable step	€ 29,367 Equity 2024: € 29,367 ▼ 17% vs 2023 (€ 35,283) Unfavourable step	€ 25,778 Equity 2025: € 25,778 ▼ 12% vs 2024 (€ 29,367) Unfavourable step	▼ 12%
Total debts	€ 24,796 Total debts 2022: € 24,796 First fiscal year in the series	€ 50,940 Total debts 2023: € 50,940 ▲ 105% vs 2022 (€ 24,796) Unfavourable step	€ 79,287 Total debts 2024: € 79,287 ▲ 56% vs 2023 (€ 50,940) Unfavourable step	€ 74,419 Total debts 2025: € 74,419 ▼ 6% vs 2024 (€ 79,287) Favourable step	▼ 6%
Cash	€ 54,250 Cash 2022: € 54,250 First fiscal year in the series	€ 51,137 Cash 2023: € 51,137 ▼ 6% vs 2022 (€ 54,250) Unfavourable step	€ 104,021 Cash 2024: € 104,021 ▲ 103% vs 2023 (€ 51,137) Favourable step	€ 66,358 Cash 2025: € 66,358 ▼ 36% vs 2024 (€ 104,021) Unfavourable step	▼ 36%
Retained profit	€ 30,678 Retained profit 2022: € 30,678 First fiscal year in the series	€ 35,283 Retained profit 2023: € 35,283 ▲ 15% vs 2022 (€ 30,678) Favourable step	€ 29,367 Retained profit 2024: € 29,367 ▼ 17% vs 2023 (€ 35,283) Unfavourable step	€ 25,778 Retained profit 2025: € 25,778 ▼ 12% vs 2024 (€ 29,367) Unfavourable step	▼ 12%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 323 Bank debt 2025: € 323 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 55,474 Balance sheet total 2022: € 55,474 First fiscal year in the series	€ 86,223 Balance sheet total 2023: € 86,223 ▲ 55% vs 2022 (€ 55,474) Unchanged	€ 108,654 Balance sheet total 2024: € 108,654 ▲ 26% vs 2023 (€ 86,223) Unchanged	€ 100,197 Balance sheet total 2025: € 100,197 ▼ 8% vs 2024 (€ 108,654) Unchanged	▼ 8%

Key figures of LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING?

What happened at LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

Jul 16, 2026 New annual accounts for financial year 2025: loss of € 3,589. Source: NBB ↗
2026 Céline VandeVyver became a director. NBB
Mar 9, 1999 Start of the company according to the CBE. KBO

In short

From € 9,626 profit in 2022 to € 3,589 loss in 2025.

Best year ever: 2022, with € 9,626 profit.

Original PDFs at the National Bank ↗

Management

Céline VandeVyver

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING

LIFE - CARE

112 Hageland

MEDICS AT HOME

Behind LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING is Céline VandeVyver. Céline VandeVyver is also behind LIFE - CARE, 112 Hageland, MEDICS AT HOME, Ellomar and Care Estate.

Directors

According to the 2025 annual accounts

Céline VandeVyver

Liquidator

Also active at: LIFE - CARE, 112 Hageland, MEDICS AT HOME, Ellomar, Care Estate

since 2026

Establishments

Establishment units

Physical locations of this company

Registered office

Steenvoordelaan 56

9050 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

UNIE VOOR DE BELGISCHE AMBULANCESECTOR

LIFE - CARE same network

€ 2 million gross margin · 2025

112 Hageland same network

€ 871,580 gross margin · 2025

MEDICS AT HOME same network

€ 931,401 gross margin · 2025

BTW GROEP LIFE-CARE

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0466.941.667

VAT number

BE 0466.941.667

Registered office

Steenvoordelaan 56, 9050 Gent

Names & denominations

LIFE-CARE DRINGENDE GENEESKUNDIGE HULPVERLENING · LIFE-CARE DGH

Enterprise type

Rechtspersoon

Legal form

Non-profit association

Legal situation

Vrijwillige ontbinding – vereffening

Start date

9 March 1999

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Patiëntenvervoer per ambulance

Ziekenvervoer

View on CBE Public ↗ Annual accounts (NBB) ↗